Jude Onyia, Chief Scientific Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 5,758 shares at $116.75 ($672K) on 2025-02-13, disclosed to the SEC on 2025-02-14.
Scheduled sale ($672k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $116.75 | 1,447 | $169K | 25.1% |
| 2 | $116.75 | 1,447 | $169K | 25.1% |
| 3 | $116.83 | 1,432 | $167K | 24.9% |
| 4 | $116.83 | 1,432 | $167K | 24.9% |
| Total | $116.79 avg | 5,758 | $672K | 100% |
| Filing → |
| NBIX | SELL | 2025-07-11 | $15.6M | — | Filing → |
| NBIX | SELL | 2025-07-07 | $5.3M | — | Filing → |
| NBIX | SELL | 2025-02-04 | $19K | — | Filing → |